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1. Introduction 
The investigation of the function of proteolytic 
enzymes in cellular metabolism has gained wide 
interest in recent years as their great importance in 
cellular regulation in prokaryotes and eukaryotes has 
been realized [l] . However, until now we are, in 
most cases, far from understanding the specific roles 
of the different proteolytic enzymes found in an 
organism. In the yeast Saccharomyces cerevisiae seven 
intracellular proteolytic enzymes have been detected 
as yet (for a review see [2,3] ). A crucial role in cellu- 
lar regulation had been attributed to one of the endo- 
proteinases, proteinase B. Cabib and coworkers had 
shown in vitro, that proteinase B is able to convert an 
inactive pro-form of chitin synthetase. an enzyme 
necessary for yeast budding and thus growth, to the 
active enzyme, and they hypothesized that proteinase 
B also regulates this reaction in vivo [4,5] . 
In vitro studies also suggested that proteinase B 
may be responsible for the catabolite inactivation of 
cytoplasmic malate dehydrogenase and fructose-l ,6- 
bisphosphatase [6-81 . Proteinase B is also believed 
to play a central role in the differentiation process of 
sporulation [9,10] . Mutants lacking proteinase B 
should permit an evaluation of the hypothesized 
functions and uncover its role in cellular metabolism. 
2. Materials and methods 
The Saccharomyces cerevisiae strain we used in 
our experiments, was the temperature sensitive cell 
lysis mutant 233 (a, cly 4-1, ade 1, ade 2, ura 1, his 
7, lys 2, tyr 1, gal 1) isolated by Hartwell and men- 
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tioned by Mortimer and Hawthorne [ 1 l] . Cells were 
grown in complete medium YPD containing 1% yeast 
extract (Difco), 2% peptone (Difco) and 2% glucose, 
supplemented with 135 mg/l adenine and 112 mg/l 
uracil. Solid medium was the growth medium supple- 
mented with 2% agar (Difco). Liquid cultures were 
grown for 72 h at 23°C into stationary phase and 
aerated by shaking. For preparation of crude extracts, 
cells were harvested by centrifugation, washed with 
distilled water, suspended in 0.1 M potassium phos- 
phate buffer, pH 7 (1: 1 ,w/v, cells: buffer) and broken 
in a French pressure cell (Aminco). Mutagenesis was 
performed with ethyl methane sulfonate (Eastman 
Organic Chemicals) according to the procedure 
described by Fink [ 121. Proteinases A and B were 
assayed as described by Saheki et al. [ 131 Carboxy- 
peptidase Y was measured according to Aibara et al. 
[ 141 . Proteinase B inhibitor activity was determined 
according to Betz et al. [ 151. Malate dehydrogenase 
was measured as outlined in [ 161. Purified pro- 
teinase B was a generous gift of Miss H. Hinze. The 
proteinase B substrates Azocoll and Hide Powder 
Azure B grade were obtained from Calbiochem. All 
other chemicals were obtained from Merck. 
3. Results and discussion 
Azocoll [5,1.5] and Hide Powder Azure [5] had 
been reported as proteinase B substrates and no other 
enzyme capable of cleaving these substrates has been 
found as yet in yeast. Thus Petri plates containing 
one of these substrates embedded in agar should 
allow detection of proteinase B activity in yeast colo- 
nies: A clearing zone around them should appear 
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owing to hydrolysis of the substrate particles by 
proteinase B, provided that solutions could be found 
for the following problems: (1) As proteinase B is an 
intracellular enzyme located in the vacuole [2,3] the 
enzyme protein must leak out of the cell. This problem 
was overcome by using a cell lysis mutant as starting 
strain. (2) After rupture of the vacuole, proteinase B 
combines with a specific inhibitor protein localized 
in the cytosol [2,3] to form an inactive complex. 
Conditions on the Petri plate leading to inhibitor 
removal are required. Saheki et al. [13] found that 
proteinase B in crude extracts could be activated by 
adjusting the pH to around 5, leading to partial 
activation of a second endoproteinase present - pro- 
teinase A - , that inactivates proteinase B inhibitor. 
Jones [ 171 reported 0.26% sodium dodecyl sulfate 
(SDS) as an activating agent of proteinase B. 
A sample of the temperature sensitive cell lysis 
strain 233 was incubated at 37°C on Petri plates 
containing Hide Powder Azure or Azocoll and tested 
both at pH 5 and in the presence of 0.26% SDS. In 
both cases there was clearing owing to proteinase B 
action. For mutant screening the following condi- 
tions were found to be most satisfactory: One Petri 
plate contained about 15 ml of growth-promoting 
solid complete medium (YPD) supplemented with 
adenine and uracil as described under materials and 
methods,O.O5%sodium dodecyl sulfate and 10 mg/ml 
Hide Powder Azure. This will be referred to as the 
screening medium. 
Isolation of proteinase B mutants proceeded as 
follows: After mutagenesis of strain 233, cells were 
plated on Petri plates containing complete medium 
supplemented with adenine and uracil and grown for 
446 days at 23’C. Then cells were replica plated onto 
the screening medium and incubated one to three 
days at 37°C. Colonies not showing a halo were picked 
from a YPD master plate incubated at 23°C. From 
about 4000-5000 colonies possible mutants were 
picked, restreaked and again tested for Hide Powder 
hydrolysis at 37°C on the screening medium. 28 
colonies did not show any clearing and were subjected 
to biochemical analysis. Crude extracts of seven of 
these colonies turned out to be absolutely devoid of 
proteinase B activity when tested using either the 
pH 5.2 activation procedure of Saheki et al. [ 131 or 
when preincubated 4-6 h at 25°C with 0.65% sodium 
dodecyl sulfate, a concentration that was found to be 
optimal under our conditions (tab. 1). Figure 1 shows 
the behaviour of four of the proteinase B mutants 
and the original strain 233 on a Hide Powder screening 
plate. To be certain that absence of proteinase B 
activity in the mutants was not caused by a lack of 
proteinase A. the enzyme that destroys proteinase B 
inhibitor during the pH 5.2 treatment [ 131 , proteinase 
A activity was also measured. Table 1 shows, that 
Table 1 
Proteinase activities of cell lysis strain 233 and mutants isolated 
Strain 
Specific activity (units/mg) 
_ 
Proteinase B 
pH 5.2 SDS 
Proteinase A Carboxypeptidase Y
pH 5.2 SDS pH 5.2 SDS 
233 
HP 58 
HP 81 
HP 163 
HP 174 
HP 232 
HP 297 
HP 333 
39 x lo-” 34 x 1o-3 2.1 1.6 6.1 X lo-3 6.5 X 10‘” 
<0.2 x lo-” <0.2x 1o-3 2.1 1.4 3.1 x lo-” 2.7 X lo-’ 
<0.2 x 10-S <0.2x 1o-3 1.4 0.8 3.7 x 1o-3 3.7 x 10-s 
<0.2 x IO-3 <0.2 x lo-” 2.2 1.2 4.7 x 1o-3 4.0 x 1o-3 
<0.2x 1o-3 <0.2 x 1o-3 0.7 0.7 3.8 X 1O-3 0.7 x 1o-3 
<0.2 x 10-S <0.2 x 10-S 1.9 2.4 5.2 X 1O-3 3.9 x 10-s 
<0.2 x lo-” <0.2x lo-” 1.7 0.8 3.4 x 1o-3 2.8 X lo-’ 
<0.2x 1o-3 <0.2x 10-a 1.2 1.1 3.5 x 1o-3 2.8 X 10-j 
Activity was measured after two different proteinase activation procedures - pH 5.2 treat- 
ment and 0.65% SDS activation - as outlined in section 3. Tests are described in section 2. 
During pH 5.2 activation procedure proteinase B activity was followed up to 160 h to detect 
any enzyme activity. Microbial growth in crude extracts was inhibited by 10e3 M NaN, 
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Fig.1. Petri plate test for Hide Powder clearing ability of 
strain 233 and mutants lacking proteinase B activity. (A) cell 
lysis strain 233; (B) HP 58; (C)HP 81, (D) HP 163; (E) HP 
232. Test was performed as outlined in section 3. 
proteinase A activity and also carboxypeptidase Y 
activity is present in ah mutants. Other possible 
explanations for the absence of proteinase B activity 
in these mutants are: (1) that the concentration of 
proteinase B inhibitor has been increased; or (2) that 
some mutation in the proteinase B-inhibitor protein 
complex has been produced and that this leads to 
failure to inactivate the inhibitor protein. These 
possibilities were tested by measuring inhibitor levels 
before and after pH 5.2 treatment. It was found that 
the mutants show no significant change in the level of 
proteinase B inhibitor compared to the wild type strain 
233 and that proteinase B inhibitor can be inactivated 
in all mutants (table 2). Thus absence of proteinase B 
activity cannot be due to some mutation affecting 
inhibitor levels or the inhibitor protein. Furthermore, 
none of the mutants showed petite phenotype, that, 
in some cases, was found to be connected with reduced 
proteinase levels [ 181. 
All seven mutants lacking proteinase B activity are 
able to grow normally and show no aberrant behaviour. 
However, cells bearing mutations affecting the budding 
event might be expected to show an abnormal pheno- 
type [ 191. Thus one might be tempted to conclude 
Table 2 
Proteinase B-inhibitor activities of cell lysis strain 233 and 
seven mutants lacking proteinase B activity before and 
after pH 5.2 treatment for proteinase B activation 
Specific activity (units/mg) 
proteinase B inhibitor 
Strain Before pH 5.2 After pH 5.2 
treatment treatment 
233 
HP 58 
HP 81 
HP 163 
HP 174 
HP 232 
HP 291 
HP 333 
-. 
1.2 0.025 
0.6 0.012 
0.8 0.048 
1.5 0.010 
1.2 0.012 
1.0 0.010 
1.4 0.008 
1.7 0.042 
Proteinase B-inhibitor activity was measured as outlined in 
section 2. Inhibitor activity was followed up to 160 h during 
pH 5.2 incubation. Boiled extracts were prepared according 
to [ 151 and protein values of these extracts were taken for 
inhibitor level calculation. As protein in boiled extracts is 
reduced lo- to 12-fold over protein in crude extracts, for 
comparison with proteinase activity, inhibitor units have to 
be devided by this factor 
that proteinase B is not involved in a vital role of the 
budding event, as is the activation of chitin synthetase 
proposed by Cabib [4] and that another mechanism 
is probably responsible for this activation. As measured 
in one of the mutants (HP 163) also glucose inactiva- 
tion of cytoplasmic malate dehydrogenase activity 
proceeds in the same way as in the wild type, indicating 
that proteinase B might not be involved in the primary 
inactivation event. 
One might raise three possible objections to our 
conclusions: (1) The residual traces of proteinase B 
inhibitory activity in all strains even after prolonged 
pH 5.2 activation procedure (table 2) are roughly 
about l/20 to l/100 of the wild type proteinase B 
activity. This residual proteinase B activity might still 
be complexed and thus undetectable. (2) The muta- 
tion in every one of the mutants might affect only 
binding or hydrolysis of Azocoll and Hide Powder 
Azure of proteinase B, leaving its activity against in 
vivo substrates intact. (3) There might exist other 
enzymes not able to cleave the synthetic substrates 
Azocoll and Hide Powder but exhibiting overlapping 
specificity with proteinase B with respect to in vivo 
123 
Volume 92, number 1 FEBS LFTTERS August 1978 
substrates. We hope to evaluate these possibilities by 
further genetic and biochemical analysis of the isolated 
mutants. 
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